PortfoliosLab logo

BioCryst Pharmaceuticals, Inc.

BCRX
Equity · Currency in USD
Sector
Healthcare
Industry
Biotechnology
ISIN
US09058V1035
CUSIP
09058V103

BCRXPrice Chart


Chart placeholderClick Calculate to get results

BCRXPerformance

The chart shows the growth of $10,000 invested in BioCryst Pharmaceuticals, Inc. on Jan 5, 2010 and compares it to the S&P 500 index or another benchmark. It would be worth nearly $21,618 for a total return of roughly 116.18%. All prices are adjusted for splits and dividends.


BCRX (BioCryst Pharmaceuticals, Inc.)
Benchmark (S&P 500)

BCRXReturns in periods

Returns over 1 year are annualized

PeriodReturn
1M-4.05%
6M21.99%
YTD97.32%
1Y309.47%
5Y26.68%
10Y17.18%

BCRXMonthly Returns Heatmap


Chart placeholderClick Calculate to get results

BCRXSharpe Ratio Chart

The Sharpe ratio shows whether the portfolio's excess returns are due to smart investment decisions or a result of taking a higher risk. The higher a portfolio's Sharpe ratio, the better its risk-adjusted performance.

The current BioCryst Pharmaceuticals, Inc. Sharpe ratio is 3.47. A Sharpe ratio of 3.0 or higher is considered excellent.

The chart below displays rolling 12-month Sharpe Ratio.


BCRX (BioCryst Pharmaceuticals, Inc.)
Benchmark (S&P 500)

BCRXDividends


BioCryst Pharmaceuticals, Inc. doesn't pay dividends

BCRXDrawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way.


BCRX (BioCryst Pharmaceuticals, Inc.)
Benchmark (S&P 500)

BCRXWorst Drawdowns

The table below shows the maximum drawdowns of the BioCryst Pharmaceuticals, Inc.. A maximum drawdown is an indicator of risk. It shows a reduction in portfolio value from its maximum due to a series of losing trades.

The maximum drawdown since January 2010 for the BioCryst Pharmaceuticals, Inc. is 90.30%, recorded on Nov 14, 2019. It took 391 trading sessions for the portfolio to recover.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-90.3%Jul 15, 20151094Nov 14, 2019391Jun 7, 20211485
-85.65%Apr 30, 2010714Mar 1, 2013213Jan 3, 2014927
-42.56%Mar 6, 201445May 8, 201437Jul 1, 201482
-41.98%Aug 11, 2014157Mar 25, 201559Jun 18, 2015216
-25.55%Jan 24, 201410Feb 6, 201412Feb 25, 201422
-24.59%Aug 6, 202141Oct 4, 2021
-23.5%Jan 12, 201020Feb 9, 201041Apr 9, 201061
-17.74%Jul 2, 201411Jul 17, 201412Aug 4, 201423
-14.68%Apr 13, 201011Apr 27, 20102Apr 29, 201013
-10.67%Jun 8, 202129Jul 19, 20214Jul 23, 202133

BCRXVolatility Chart

Current BioCryst Pharmaceuticals, Inc. volatility is 39.97%. The chart below shows the rolling 10-day volatility. Volatility is a statistical measure showing how big price swings are in either direction. The higher asset volatility, the riskier it is, because the price movements are less predictable.


BCRX (BioCryst Pharmaceuticals, Inc.)
Benchmark (S&P 500)

Portfolios with BioCryst Pharmaceuticals, Inc.


Loading data...

More Tools for BioCryst Pharmaceuticals, Inc.